Literature DB >> 7679218

Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth.

P N Pharr1, D Hankins, A Hofbauer, H F Lodish, G D Longmore.   

Abstract

We tested the ability of a constitutively activated erythropoietin receptor [EpoR(R129C)] to alter the growth requirements of primary hematopoietic precursors that terminally differentiate in culture. Two recombinant retroviruses expressing EpoR(R129C), spleen focus-forming virus (SFFVc-EpoR) and myeloproliferative sarcoma virus (MPSVcEpoR), were used to infect fetal liver cells that served as a source of hematopoietic progenitors. Methylcellulose cultures were incubated in the absence of any added growth factors or in combination with selected growth factors. EpoR(R129C) completely abrogated the Epo requirement of erythroid colony-forming units to form erythrocytes after 2-5 days in culture and did not interfere with the differentiation program of these cells. In the absence of added growth factors EpoR(R129C) did not enhance erythroid burst-forming unit development. In contrast to experiments in heterologous cell lines, EpoR(R129C) did not render progenitor cells independent of interleukin 3 or granulocyte/macrophage colony-stimulating factor (GM-CSF). However, when progenitors were cultured with added steel factor, but not with interleukin 3 or GM-CSF, EpoR(R129C) augmented the growth and differentiation of erythroid bursts, mixed erythroid/myeloid, and granulocyte/macrophage (GM) colonies. Furthermore, both viruses were capable of expressing EpoR(R129C) in erythroid, mixed erythroid/myeloid, and GM colonies. Thus an aberrantly expressed and constitutively activated EpoR can stimulate proliferation of some GM progenitors. The ability of EpoR(R129C) to abrogate the Epo requirement of primary hematopoietic cells, but not the requirement for other cytokines, is consistent with the induction of erythroblastosis in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679218      PMCID: PMC45785          DOI: 10.1073/pnas.90.3.938

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Human burst-forming units-erythroid need direct interaction with stem cell factor for further development.

Authors:  C H Dai; S B Krantz; K M Zsebo
Journal:  Blood       Date:  1991-11-15       Impact factor: 22.113

2.  The role of erythropoietin in regulation of population size and cell cycling of early and late erythroid precursors in mouse bone marrow.

Authors:  N N Iscove
Journal:  Cell Tissue Kinet       Date:  1977-07

3.  An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: a cytokine receptor superfamily oncogene.

Authors:  G D Longmore; H F Lodish
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

4.  Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro.

Authors:  G Migliaccio; A R Migliaccio; M L Druzin; P J Giardina; K M Zsebo; J W Adamson
Journal:  J Cell Physiol       Date:  1991-09       Impact factor: 6.384

5.  Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells.

Authors:  H E Broxmeyer; S Cooper; L Lu; G Hangoc; D Anderson; D Cosman; S D Lyman; D E Williams
Journal:  Blood       Date:  1991-05-15       Impact factor: 22.113

6.  Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis.

Authors:  O Miura; A D'Andrea; D Kabat; J N Ihle
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

7.  Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors.

Authors:  A G Leary; H Q Zeng; S C Clark; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

8.  Direct and synergistic effects of interleukin 11 on murine hemopoiesis in culture.

Authors:  M Musashi; Y C Yang; S R Paul; S C Clark; T Sudo; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

9.  In vitro phosphorylation of the erythropoietin receptor and an associated protein, pp130.

Authors:  A Yoshimura; H F Lodish
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

10.  Ligand stimulation of transfected and endogenous growth factor receptors enhances cytokine production by mast cells.

Authors:  A D Keegan; J H Pierce; J Artrip; M Plaut; W E Paul
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  22 in total

1.  Characterization of purified intraembryonic hematopoietic stem cells as a tool to define their site of origin.

Authors:  Julien Y Bertrand; Sébastien Giroux; Rachel Golub; Michèle Klaine; Abdelali Jalil; Laurent Boucontet; Isabelle Godin; Ana Cumano
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-27       Impact factor: 11.205

2.  Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.

Authors:  C T Quang; O Wessely; M Pironin; H Beug; J Ghysdael
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

3.  Control of hematopoietic differentiation: lack of specificity in signaling by cytokine receptors.

Authors:  M Socolovsky; H F Lodish; G Q Daley
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

4.  Erythropoietin receptors that signal through Stat5 or Stat3 support fetal liver and adult erythropoiesis: lack of specificity of stat signals during red blood cell development.

Authors:  S S Watowich; A Mikami; R A Busche; X Xie; P N Pharr; G D Longmore
Journal:  J Interferon Cytokine Res       Date:  2000-12       Impact factor: 2.607

5.  JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.

Authors:  Jiahai Shi; Bingbing Yuan; Wenqian Hu; Harvey Lodish
Journal:  Exp Hematol       Date:  2016-07-26       Impact factor: 3.084

Review 6.  Hematopoietic growth factors, signaling and the chronic myeloproliferative disorders.

Authors:  Kenneth Kaushansky
Journal:  Cytokine Growth Factor Rev       Date:  2006-10-20       Impact factor: 7.638

7.  Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.

Authors:  K Luo; H F Lodish
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

8.  Constitutive activation of a variant of the env-mpl oncogene product by disulfide-linked homodimerization.

Authors:  G Courtois; L Bénit; Y Mikaeloff; M Pauchard; M Charon; P Varlet; S Gisselbrecht
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Activation and inhibition of erythropoietin receptor function: role of receptor dimerization.

Authors:  S S Watowich; D J Hilton; H F Lodish
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Dysregulated hematopoiesis and a progressive neurological disorder induced by expression of an activated form of the human common beta chain in transgenic mice.

Authors:  R J D'Andrea; D Harrison-Findik; C M Butcher; J Finnie; P Blumbergs; P Bartley; M McCormack; K Jones; R Rowland; T J Gonda; M A Vadas
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.